31/01/2026
Project successfully delivered! ✔️🇱🇷
👉 In eight different hospital sites, some in the most remote corners of Liberia, we have just completed a project that embodies what Yess Pharma GmbH stands for: bringing high‑quality medical technology to places where it is hardest to deliver.
👉 Together with our local partner, we equipped and commissioned critical diagnostic and neonatal care infrastructure for Welthungerhilfe in an environment marked by limited roads, unreliable power supply and challenging logistics. Every piece of equipment in the photos had to overcome these hurdles before it could start saving lives.
👉 What makes this project special is not only the volume of equipment, but the fact that everything was fully installed, calibrated and tested on site. From neonatal warmers and phototherapy units to examination lights, oxygen concentrators and laboratory devices, our teams worked room by room to transform empty spaces into functioning clinical environments.
👉 Equally important was hands‑on training. Together with our partners from DCL, we conducted intensive sessions with local clinicians, technicians and lab personnel, focusing on daily operation, troubleshooting and basic maintenance.
👉 We are also proud that this work has been approved and supported by Partners In Health-Liberia, underlining the clinical and technical standards applied throughout the project. Their endorsement confirms that the solution we implemented is aligned with international best practice while being adapted to local realities. It also highlights the value of close cooperation between global and local actors when strengthening health systems in fragile settings.
👉 For Yess Pharma GmbH, this project in Liberia is more than a successful delivery: it is proof that a small, highly specialized team with strong partners can implement complex medical technology projects under extremely difficult conditions. We are grateful to Welthungerhilfe for their trust, to DCL for their tireless work on the ground, and to Partners in Health for their guidance. Most of all, we are motivated by the knowledge that these devices will directly support better care for mothers, newborns and patients in a region that has been underserved for far too long. 🚑
